Investment Strategy
An experienced committee of researchers and clinicians at The University of Texas MD Anderson Cancer Center conducts scientific diligence on all opportunities prior to any investment.
The University of Texas MD Anderson Cancer Center will design and execute clinical trials for Focus Fund investments. Portfolio companies will be able to leverage the cancer center’s best-in-class facilities and services with the goal of executing clinical trials with maximized potential for success.
We expect to invest in approximately 10 to 12 promising therapies. Up to 20% of committed capital may be designated for special situations, including earlier or future rounds of financing for portfolio companies.
Key Differentiators
Exclusive arrangement with The University of Texas MD Anderson Cancer Center.
-
- MDACC provides scientific diligence on target assets through the dedicated Scientific Advisory Board composed of leading clinicians and innovators.
- MDACC’s investment in the Cancer Focus Fund allows for standardized protocols and streamlined contractual review, therefore lowering the upfront financial burden.
Respected Fund leadership from across the healthcare ecosystem with years of diverse specialist experience.
Staggered capital-infusion strategy provides opportunities for the Fund.
-
- Structured to provide return of capital early if Fund deems prudent, or flexibility for longer hold period